RSS-Feed abonnieren
DOI: 10.1055/s-0030-1249700
© Georg Thieme Verlag KG Stuttgart · New York
Preconceptional Oral Vaccination Prevents Experimental Biliary Atresia in Newborn Mice
Publikationsverlauf
received January 16, 2010
accepted after revision February 21, 2010
Publikationsdatum:
12. April 2010 (online)

Abstract
Introduction: Biliary atresia (BA) in humans resembles BA induced in Balb/c-mice by Rhesus Rotavirus (RRV). In mice, susceptibility to BA is ascribed to the lack of maternally derived immune protection. This study investigated whether vaccination of dams against RRV protected their offspring from developing BA.
Materials and Methods: Before mating, female mice were vaccinated orally with RotaTeq® or Rotarix®. Pups (n=243) from both test groups and a control group were intraperitoneally infected with RRV. Sacrifice of the animals was scheduled for days 7, 14 and 21 after infection. Then, gross and mircoscopia findings of the liver and the hepatoduodenal ligament gave evidence of BA, and hepatic viral load was tested by virus-specific real-time PCR, as well as plaque forming units.
Results: Two weeks after infection, the incidence of cholestasis was 100% in controls, 77% in pups of RotaTeq®-vaccinated dams, and 56% in pups of Rotarix®-vaccinated dams. However, in contrast to controls (incidence of BA: 82%) most pups in the test groups recovered (incidence of BA in pups of RotaTeq®-vaccinated dams 11%; incidence of BA in pups of Rotarix®-vaccinated dams 3%). Hepatic viral load was identical at various time-points in all pups, suggesting that differences in RRV clearance did not underlie this effect.
Conclusion: In this mouse model, oral vaccination with RotaTeq® and Rotarix® prevented most RRV-induced BA. This provides a new approach to a better understanding of both the pathomechanism of BA development and the capabilities of the innate immune system. It also suggests a first approach for prophylaxis against BA.
Key words
biliary atresia - mouse model - rhesus rotavirus - vaccination - prevention
References
- 1
Balistreri WF, Grand R, Hoofnagle JH. et al .
Biliary atresia: current concepts and research directions.
Summary of a symposium. Hepatology.
1996;
23
1682-1692
MissingFormLabel
- 2
Sokol RJ, Mack C, Narkewicz MR. et al .
Pathogenesis and outcome of biliary atresia: current concepts.
J Pediatr Gastroenterol Nutr.
2003;
37
4-21
MissingFormLabel
- 3
Petersen C.
Pathogenesis and treatment opportunities for biliary atresia.
Clin Liver Dis.
2006;
10
73-88
, vi [Review]
MissingFormLabel
- 4
Perlmutter DH, Shepherd RW.
Extrahepatic biliary atresia: a disease or a phenotype?.
Hepatology.
2002;
35
1297-1304
MissingFormLabel
- 5
Petersen C, Kuske M, Bruns E. et al .
Progress in developing animal models for biliary atresia.
Eur J Pediatr Surg.
1998;
8
137-141
MissingFormLabel
- 6
Crawford SE, Patel DG, Cheng E. et al .
Rotavirus viremia and extraintestinal viral infection in the neonatal rat model.
J Virol.
2006;
80
4820-4832
MissingFormLabel
- 7
Petersen C, Biermanns D, Kuske M. et al .
New aspects in a murine model for extrahepatic biliary atresia.
J Pediatr Surg.
1997;
32
1190-1195
MissingFormLabel
- 8
Czech-Schmidt G, Verhagen W, Szavay P. et al .
Immunological gap in the infectious animal model for biliary atresia.
J Surg Res.
2001;
1011
62-67
MissingFormLabel
- 9
Bezerra JA.
The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary
atresia.
J Pediatr Gastroenterol Nutr.
2006;
1
S23-29
MissingFormLabel
- 10
Landing BH.
Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal
cyst-the concept of infantile obstructive cholangiopathy.
Prog Pediatr Surg.
1974;
6
113-139
MissingFormLabel
- 11
Mack CL.
The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease.
Semin Liver Dis.
2007;
27
233-242
MissingFormLabel
- 12
Kuebler JF, Czech-Schmidt G, Leonhardt J. et al .
Type-I but not type-II interferon receptor knockout mice are susceptible to biliary
atresia.
Pediatr Res.
2006;
59
790-794
MissingFormLabel
- 13
Vesikari T, Matson DO, Dennehy P. et al .
Rotavirus Efficacy and Safety Trial (REST) Study. Team Safety and efficacy of a pentavalent
human-bovine (WC3) reassortant rotavirus vaccine.
N Engl J Med.
2006;
354
23-33
MissingFormLabel
- 14
Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR. et al .
Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine
against severe rotavirus gastroenteritis.
N Engl J Med.
2006;
354
11-22
MissingFormLabel
- 15
Glass RI, Parashar UD.
The promise of new rotavirus vaccines.
N Engl J Med.
2006;
354
75-77
MissingFormLabel
- 16
Riepenhoff-Talty M, Schaekel K, Clark HF. et al .
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated
newborn mice.
Pediatr Res.
1993;
33
394-399
MissingFormLabel
- 17
Mack CL, Tucker RM, Lu BR. et al .
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary
atresia.
Hepatology.
2006;
44
1231-1239
MissingFormLabel
- 18
Bezerra JA, Tiao G, Ryckman FC. et al .
Genetic induction of proinflammatory immunity in children with biliary atresia.
Lancet.
2002;
360
1653-1659
MissingFormLabel
- 19
Shivakumar P, Campbell KM, Sabla GE. et al .
Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in
experimental biliary atresia.
J Clin Invest.
2004;
114
322-329
MissingFormLabel
- 20
Petersen C, Bruns E, Kuske M. et al .
Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious
model.
Pediatr Res.
1997;
42
623-628
MissingFormLabel
- 21
Leonhardt J, Stanulla M, von Wasielewski R. et al .
Gene expression profile of the infective murine model for biliary atresia.
Pediatr Surg Int.
2006;
22
84-89
MissingFormLabel
- 22
Mohanty SK, Shivakumar P, Sabla G. et al .
Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent
duct obstruction in experimental biliary atresia.
BMC Gastroenterol.
2006;
6
14
MissingFormLabel
- 23
Carvalho E, Liu C, Shivakumar P. et al .
Analysis of the biliary transcriptome in experimental biliary atresia.
Gastroenterology.
2005;
129
713-717
MissingFormLabel
- 24
Mack CL, Tucker RM, Sokol RJ. et al .
Armed CD4+ Th1 effector cells and macrophages participate in bile duct injury in murine
biliary atresia.
Clin Immunol.
2005;
115
200-209
MissingFormLabel
- 25
Mack CL, Tucker RM, Sokol RJ. et al .
Biliary atresia is associated with CD4+ Th1 cell-mediated portal-tract inflammation.
Pediatr Res.
2004;
56
9-10
MissingFormLabel
- 26
Mack CL, Falta MT, Sullivan AK. et al .
Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with
biliary atresia.
Gastroenterology.
2007;
133
278-287
MissingFormLabel
- 27
Oldstone MB.
Molecular and cellular mechanisms, pathogenesis, and treatment of insulin-dependent
diabetes obtained through study of transgenic model of molecular mimicry.
Curr Top Microbiol Immunol.
2005;
296
65-87
MissingFormLabel
- 28
Bondoc AJ, Jafri MA, Donnelly B. et al .
Prevention of the murine model of biliary atresia after live rotavirus vaccination
of dams.
J Pediatr Surg.
2009;
44
1479-1490
MissingFormLabel
- 29
Martin D, Rioux S, Gagnon E. et al .
Protection from group B streptococcal infection in neonatal mice by maternal immunization
with recombinant sip protein.
Infect Immun.
2002;
70
4897-4901
MissingFormLabel
- 30
Ward RL.
Rotavirus vaccines: how they work or don't work.
Expert Rev Mol Med.
2008;
12
10: e5
MissingFormLabel
- 31
Ward RL.
Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined
with the adult mouse model.
Viral Immunol.
2003;
16
17-24
MissingFormLabel
- 32
Shivakumar P, Sabla G, Mohanty S. et al .
Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity
in experimental biliary atresia.
Gastroenterology..
2007;
133
268-277
MissingFormLabel
Correspondence
Dr. Carmen TurowskiMD
Hannover Medical School
Pediatric Surgery
Carl-Neuberg-Straße 1
30625 Hannover
Germany
Telefon: +49 511 532 9260
Fax: +49 511 532 9059
eMail: turowski.carmen@mh-hannover.de